NeuroOne Medical Technologies Reports Proposed Public Offering of Common Stock
Oct 13, 2021 By MarketDepth
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) has announced a proposed underwritten registered public offering of shares of common stock. NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs.
Stock Offering by Company
All shares of common stock to be sold in the proposed offering will be sold by the Company. The company plants to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the offering. The offering is subject to market and other conditions as there is no assurance when the offering may be completed or to sum up the actual size or terms of the offering. The company plans to utilize the net proceeds from this offering for working capital and other general corporate purposes. Craig-Hallum Capital Group acts as the sole managing underwriter for the proposed offering.
